Osamu Uchikawa

Affiliations

Towa Pharmaceutical Co., Ltd, Osaka, Japan.

Réseau de co-auteurs

Takayuki Kondo 1 collaboration

Haruhiko Banno 1 collaboration

Taro Okunomiya 1 collaboration

Yoko Amino 1 collaboration

Kayoko Endo 1 collaboration

Akiyoshi Nakakura 1 collaboration

Ryuji Uozumi 1 collaboration

Akemi Kinoshita 1 collaboration

Harue Tada 1 collaboration

Satoshi Morita 1 collaboration

Hidehiro Ishikawa 1 collaboration

Akihiro Shindo 1 collaboration

Ken Yasuda 1 collaboration

Yosuke Taruno 1 collaboration

Takakuni Maki 1 collaboration

Takashi Suehiro 1 collaboration

Kohji Mori 1 collaboration

Manabu Ikeda 1 collaboration

Koji Fujita 1 collaboration

Yuishin Izumi 1 collaboration

Kazutomi Kanemaru 1 collaboration

Kenji Ishii 1 collaboration

Kazue Shigenobu 1 collaboration

Yumiko Kutoku 1 collaboration

Yoshihide Sunada 1 collaboration

Shinobu Kawakatsu 1 collaboration

Shunji Shiota 1 collaboration

Toshifumi Watanabe 1 collaboration

Ryosuke Takahashi 1 collaboration

Hidekazu Tomimoto 1 collaboration

Haruhisa Inoue 1 collaboration

Yasutaka Hoashi 1 collaboration

Takafumi Takai 1 collaboration

Yohei Kosugi 1 collaboration

Masato Nakashima 1 collaboration

Masaharu Nakayama 1 collaboration

Keisuke Hirai 1 collaboration

Tatsuki Koike 1 collaboration

Shohei Fukuda 1 collaboration

Yumiko Nakase 1 collaboration

Kazuhide Imagaki 1 collaboration

Kanako Kondo 1 collaboration

Takahiko Taniguchi 1 collaboration

Osamu Uchikawa

Affiliations

Publications (3)

Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations.

Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist.

Simple and Practical Method for the Quantitative High-Sensitivity Analysis of

Réseau de co-auteurs